Shares of IXICO plc (LON:IXI – Get Free Report) crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of GBX 7.71 and traded as high as GBX 7.80. IXICO shares last traded at GBX 7.80, with a volume of 166,218 shares changing hands.
IXICO Stock Performance
The company has a 50-day moving average price of GBX 7.71 and a two-hundred day moving average price of GBX 7.85. The stock has a market capitalization of £16.82 million, a P/E ratio of -3.94, a PEG ratio of -0.38 and a beta of 0.11. The company has a quick ratio of 4.90, a current ratio of 2.83 and a debt-to-equity ratio of 5.22.
Insider Buying and Selling
In other news, insider Mark Warne acquired 50,006 shares of IXICO stock in a transaction that occurred on Wednesday, July 15th. The stock was bought at an average price of GBX 8 per share, with a total value of £4,000.48. Corporate insiders own 3.07% of the company’s stock.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
